ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
Copyright ©2018 Mattioli1885 | VAT: 00579710344 | All Rights Reserved.